Robeco Institutional Asset Management B.V. Regeneron Pharmaceuticals, Inc. Transaction History
Robeco Institutional Asset Management B.V.
- $66.7 Billion
- Q3 2025
A detailed history of Robeco Institutional Asset Management B.V. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 120,884 shares of REGN stock, worth $78.2 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
120,884
Previous 47,708
153.38%
Holding current value
$78.2 Million
Previous $25 Million
171.38%
% of portfolio
0.1%
Previous 0.04%
Shares
42 transactions
Others Institutions Holding REGN
# of Institutions
1,443Shares Held
89MCall Options Held
1.77MPut Options Held
1.75M-
Vanguard Group Inc Valley Forge, PA9.42MShares$6.1 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.46 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.66 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.13 Billion0.1% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.48 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $69.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...